This Solicitation opportunity from Department Of Defense was posted on September 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

TEST KIT, CUTANEOUS LEI

Closed

SPE2DS-26-T-450PFederal

Submission Closed09/23/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

Solicitation # SPE2DP-27-T-0251

Solicitation SPE2DP-27-T-0251 is a fixed-price procurement issued by the Defense Logistics Agency for the supply of veterinary Maropitant Citrate 160mg tablets. The requirement is for 4 packages, with each package consisting of a blister pack containing 4 tablets per perforated sheet. This FDA-regulated drug must be stored at a controlled room temperature of 20-25 C (68-77 F), allowing for excursions between 15-30 C (59-86 F), and carries a non-extendable shelf life of 36 months. Delivery is set for November 5, 2026, with a delivery timeline of 88 days ADO, shipped FOB Destination to the USA Med Mat Ctr Eur in Kaiserslautern, Germany. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires packaging to follow MIL-STD-2073-1E and DLA packaging requirements. Each unit must be in a sealed container to prevent damage, and shipping must utilize suitable commercial exterior containers. Administrative requirements include the use of the Wide Area Workflow system for invoicing and compliance with the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold. Offerors must submit quotations via the DIBBS portal by November 12, 2026, and provide necessary representations regarding small business status and covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0250

Solicitation SPE2DP-27-T-0250, issued by the Defense Logistics Agency (DLA) Medical Supply Chain Pharm FSA, is for the procurement of surgical lubricant. The required product is a sterile, bacteriostatic, latex-free, water-soluble jelly containing parabens. Each unit of issue is a box containing 144 foil packets, with each packet containing 2.7 grams of lubricant. The item is regulated by the FDA and must be stored between 20° to 25°C (68° to 77°F). It is classified as a TYPE I (CODE Q) item with a non-extendable shelf life of 36 months. The contract requires a total of 3 boxes (NSN 6505-01-626-5774) to be delivered FOB Destination to Yokota Air Base, Japan, and Ramstein Flugplatz, Germany, within 5 days of the order. Packaging must be commercial and compliant with MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. The solicitation incorporates various DFARS and FAR clauses, including requirements for cybersecurity reporting, the Berry Amendment, and the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CATHETER AND NEEDLE UN

Solicitation # SPE2DS-27-T-1499

This fixed-price solicitation, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of 30 intravenous catheter and needle units designed for pneumothorax decompression. The required units must be 14 gauge by 3.25 inches long, featuring a Luer-Lock, radiopaque, disposable, sterile, and latex-free design, constructed with an F.E.P. polymer catheter and a stainless steel needle. The items are to be delivered FOB Destination to Fort Bragg, North Carolina, with a required delivery window of 20 days after the order. The contract mandates strict adherence to DLA Master List technical and quality requirements, with packaging following ASTM D3951 and marking complying with MIL-STD-129 and Medical Marking Standard No. 1. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The solicitation is governed by various FAR and DFARS clauses, including the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity assessment requirements. All quotes must be submitted via the DIBBS portal, and bidders are required to specify the source and part number of the supplied items.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

OCLACITINIB MALEATE TA

Solicitation # SPE2DP-27-T-0249

Solicitation SPE2DP-27-T-0249 is for the procurement of Oclacitinib Maleate Tablets, branded as Apoquel 16mg, used to treat atopic dermatitis and pruritus associated with allergic dermatitis in dogs. The requirement is for one bottle containing 100 tablets, with a non-extendable shelf life of 36 months. The product is FDA-regulated and must be stored at a controlled room temperature between 20 and 25 degrees Celsius, with permitted excursions between 15 and 40 degrees Celsius. Delivery is required within 89 days after order, with the final destination located in Kaiserslautern, Germany. The contract specifies that packaging and packing must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to ensure safe delivery. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. This acquisition is managed by the DLA Troop Support Medical Supply Chain PHARM FSA and utilizes the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses, including requirements for cybersecurity reporting, the Buy American Act, and specific DLA packaging and palletization standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MEDIUM, FECAL FLOATATIO

Solicitation # SPE2DP-27-T-0252

This fixed-price contract, solicitation SPE2DP-27-T-0252, is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one gallon of veterinary fecal flotation medium. The specific requirement is for Dry Fecal Flotation Ovasol with Zinc Sulfate, manufactured by Jice Pharm Co., used for the identification of ova. The item is regulated by the FDA and must be stored at USP controlled room temperature between 20 and 25 degrees Celsius, with permitted excursions from 15 to 30 degrees Celsius. The product has a non-extendable shelf life of 60 months. Delivery is specified as FOB Destination to the W0CC USA Med Mat Ctr EUR in Kaiserslautern, Germany, with a required delivery date of November 5, 2026, and a delivery window of 88 days after order. Packaging must be commercial and compliant with MIL-STD-2073-1E, while marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The acquisition is a Small Business Set-Aside under NAICS code 456199. Key regulatory requirements include DFARS 252.204-7012 for safeguarding covered defense information and DFARS 252.225-7001 regarding the Buy American and Balance of Payments Program. All payment requests and receiving reports must be processed electronically via the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DETECTOR KIT, FRACTURE,

Solicitation # SPE2DH-27-T-0412

Solicitation SPE2DH-27-T-0412, issued by the Defense Logistics Agency (DLA) Medical Supply Chain, is for the procurement of dental fracture detector kits (NSN 6520-01-642-2309). Each kit is designed to detect fractures and hard-to-find root canal orifices using methylene blue and must include one 10ml dropper bottle, 24 micro applicator brushes, and six mixing wells. The requirement is for one kit to be delivered FOB Destination to the USNS Comfort (FPO AE 09566-4008) within 20 days after receipt of order. The contract mandates strict adherence to Medical Marking Standard No. 1 and commercial packaging standards to protect contents from damage. Bidders must provide source and part numbers and are encouraged to submit quantity ranges due to demand volatility. Administrative requirements include the use of Wide Area WorkFlow (WAWF) for electronic invoicing and compliance with various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment. The response deadline for quotations is November 12, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

CONTROL SET, HUMAN SERU

Solicitation # SPE2DS-27-T-1192

Solicitation SPE2DS-27-T-1192 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one set of i-STAT CK-MB Calibration Verification 1-3 human serum controls (NSN 6550-01-627-2276). These controls are used as a calibration mechanism for Creatine Kinase MB mass controls to assist in the diagnosis and treatment of myocardial infarction. Each set must contain six vials, consisting of two 1 mL vials for each of the three levels. The items must have a non-extendable shelf life of 12 months, and no more than two months may have elapsed from the date of manufacture to the date of delivery to the government. The contract requires delivery within 20 days after the order, with a required delivery date of November 3, 2026, shipped FOB Destination to the USNS Comfort. Packaging must be commercial and utilize suitable sealed unit containers, with markings adhering to Medical Marking Standard No. 1 (MMS1A). Labels must clearly state the manufacturer date, expiration or retest date, and the contract or lot number. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various DFARS and FAR clauses, including safeguarding covered defense information and restrictions on covered telecommunications equipment. Offerors must submit their quotations via the DIBBS portal by November 9, 2026, and provide specific source and part numbers. The procurement also mandates compliance with the Buy American Act and the Berry Amendment regarding domestic sourcing.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CLAMP, HEMORRHAGE CONTR

Solicitation # SPE2DS-27-T-1189

Solicitation SPE2DS-27-T-1189 is a procurement request by the Defense Logistics Agency for the supply of iT Clamps, which are combat-ready hemorrhage control wound closure devices. These sterile devices, constructed from medical grade polycarbonate plastic and stainless steel, are designed for rapid control of severe bleeding and can be self-applied or buddy-applied. Design control for the product is held by Innovative Trauma Care. The requirement consists of two line items for NSN 6515-01-629-7044, with quantities of 2 and 4 units respectively. Delivery is specified as FOB Destination, with shipping addresses including the USNS Henson and USNS Lewis and Clark, and a required delivery date of November 3, 2026. The contract mandates strict adherence to quality and packaging standards, including MIL-STD-129 for marking, ASTM D3951 for packaging, and the Medical Marking Standard No. 1. All items are subject to a non-extendable shelf life of 48 months. Compliance with the Buy American Act, Berry Amendment, and DFARS cybersecurity requirements for safeguarding covered defense information is required. Invoicing must be processed electronically through the Wide Area WorkFlow system. Offerors must provide a complete data package for any alternate part submissions and validate their status within the System for Award Management.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Respirator Cleaning Wipes for Wright-Patterson AFBThis subcontract, issued by the Defense Logistics Agency under the Department of Defense, governs the procurement and one-time delivery of six boxes of respirator cleaning wipes. The supplies are to be delivered to Wright-Patterson Air Force Base in Ohio, with shipping terms established as FOB Destination. The agreement requires strict adherence to DFARS and DPAS regulations to ensure regulatory compliance and priority handling. The contract is categorized under NAICS code 456199 and was posted on June 29, 2026.

Defense Logistics Agency

POSTED

4 months ago

DEADLINE

N/A

AI Contract Overview

Solicitation SPE2DS-26-T-450P is a request for quotations issued by DLA Troop Support for the acquisition of two kits of FDA-cleared, hand-held, qualitative, in vitro immunochromatographic assays for the rapid detection of Leishmania species antigen in ulcerative skin lesions. The required items, identified by NSN 6550016339195, are intended for use with samples obtained via dental broach from lesions less than four months old. The kits must have a non-extendable shelf life of 18 months and can be stored at room temperature. Delivery is required within 83 days of order, with a target delivery date of September 17, 2026. The contract is FOB Destination, with both inspection and acceptance occurring at the destination. Shipping addresses are provided for both parcel post and freight in Germany. Packaging must comply with MIL-STD-2073-1E and commercial standards, while marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The procurement is subject to various federal regulations, including the Buy American Act and the Berry Amendment. Bidders must submit quotes via the DIBBS system and provide specific source and part number information. Invoicing and payment will be processed through the Wide Area WorkFlow system. The primary point of contact for this acquisition is Seth Tootell.

General Info

DLA Troop Support seeks quotes for two Leishmania antigen detection kits by 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

NAICS

456199 - All Other Health and Personal Care Retailers

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USA

Set-Aside

NONE

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 17

Solicitation

Response DeadlineSep 23

Deadline has passed

Submission Closed

09/23/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Office AddressUSA

Contacts

Seth Tootell

contact@example.gov

+1 (555) 000-0000

Full Description

TEST KIT,CUTANEOUS LEISHMANIASIS DETECTI
TEST KIT, CUTANEOUS LEISHMANIASIS DETECTION
CL DETECT RAPID TEST FOR CUTANEOUS
LEISHMANIASIS; FDA-CLEARED, HAND-HELD<(>,<)>
QUALITATIVE, IN VITRO IMMUNOCHROMATOGRAPHIC
ASSAY FOR THE RAPID DETECTION OF LEISHMANIA
SPECIES ANTIGEN IN ULCERATIVE SKIN LESIONS;
INTENDED FOR USE WITH SAMPLES TAKEN WITH A
DENTAL BROACH FROM ULCERATIVE SKIN LESIONS
LESS THAN FOUR MONTHS OLD OBTAINED FROM
PATIENTS WITH SUSPECTED CUTANEOUS
LEISHMANIASIS (CL); FOR 25 TESTS
.
UNIT OF ISSUE KIT, KT
.
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
. CAN BE STORED AT ROOM TEMPERATURE . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
BIDDER SHALL SPECIFY SOURCE AND
PART NUMBER BEING SUPPLIED.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SPE2DS-26-T-450P
SECTION B
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
INBIOS INTERNATIONAL INC 3KJL6 P/N CL025
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018405057 0001 KT 2.000
NSN/MATERIAL:6550016339195
DELIVERY (IN DAYS):0083
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
SPE2DS-26-T-450P
SECTION B
PR: 7018405057 PRLI: 0001 CONT’D
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
CMR 469
ATTN CL VIII MED REQ PROCES ACT
APO AE 09227-0000
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
USAMMC E DISTR AND TRANS DIVISION
LUDWIGSHAFENERSTRASSE 31 BLDG 2369
KAISERSLAUTERN 67657
DE
Need Ship Date:00/00/0000 Original Required Delivery Date:09/17/2026
SPE2DS-26-T-450P NSN/Part Number: 6550-01-633-9195 Quantity: 2 KT Purchase Request: 7018405057QTY: 2 Delivery: 83 days ADO